The AstraZeneca’s vaccine named ‘ Covishield’, which was widely administered in India, was manufacture by the Serum...
Now AstraZeneca is facing lawsuit in the UK following reports of deaths and severe injuries with as many as 51 cases...
The research, published recently in the journal PLOS One, was carried out to determine the impact of COVID-19...
The UK's Office for National Statistics published a study on the effects of Covid infection and vaccination risk on...
He published a research that claimed that the harms of the vaccine outweigh the benefits for a majority of the...
The emergence of a new dangerous variant of coronavirus is the main concern.
In the affidavit filed on November 23, the Health Ministry said that though the government strongly encourages all...
In the face of dropping demand, one of the world’s biggest vaccine maker Serum Institute of India (SII) will stop...
A third 'precautionary' dose of the Covid-19 vaccine will be administered to thousands of healthcare workers and elderly...
New Delhi: Serum Institute has requested the Indian health ministry and Central Drugs Standard Control Organisation...
Pune: Serum Institute of India's head Adar Poonawalla has revealed that the vaccine producer is in a dilemma over...
India has resumed exporting low-cost Covishield vaccines to middle and lower-income countries around the world via the...
The Serum Institute of India is set to resume export of the Covishield vaccine to the international COVAX programme in...
New Delhi: In what would ease travel for education, business and tourism purposes, 110 countries have agreed to...